SLC2A1 and colorectal cancer: Furthermore, the exposition of wild type colorectal cancer cell lines to low levels of glucose contributes to the development of mutations in KRAS, which give rise, instead, to the upregulation of GLUT1 and to an increase in glucose uptake [53].